Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
This study is ongoing, but not recruiting participants.
Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborators:
University School of Medicine(VA-NYU)
State University of New York - Downstate Medical Center
Kings County Hospital Center
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00581672
First received: December 21, 2007
Last updated: October 5, 2015
Last verified: October 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).
| Condition | Intervention |
|---|---|
|
Prostate Cancer |
Behavioral: questionnaires of quality of life |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men |
Resource links provided by NLM:
Further study details as provided by Memorial Sloan Kettering Cancer Center:
Primary Outcome Measures:
- To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 225 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | December 2016 |
| Estimated Primary Completion Date: | December 2016 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
questionnaires
Black men with prostate cancer
|
Behavioral: questionnaires of quality of life
Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Black men with prostate cancer
Criteria
Inclusion Criteria:
- 18 years of age or older
- Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
- Diagnosis of prostate cancer
- Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
- Ability to comprehend and complete questionnaires in English
Exclusion Criteria:
- Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
- Other non-Black or non-African-American ethnic groups
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00581672
Please refer to this study by its ClinicalTrials.gov identifier: NCT00581672
Locations
| United States, New York | |
| Downstate Medical Center | |
| Brooklyn, New York, United States, 11203 | |
| Kings County Hopsital Center | |
| Brooklyn, New York, United States | |
| Memorial Sloan Kettering Cancer Center | |
| New York, New York, United States, 10065 | |
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
University School of Medicine(VA-NYU)
State University of New York - Downstate Medical Center
Kings County Hospital Center
Investigators
| Principal Investigator: | Christian Nelson, PhD | Memorial Sloan Kettering Cancer Center |
More Information
Additional Information:
| Responsible Party: | Memorial Sloan Kettering Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00581672 History of Changes |
| Obsolete Identifiers: | NCT00602654 |
| Other Study ID Numbers: | 07-125 |
| Study First Received: | December 21, 2007 |
| Last Updated: | October 5, 2015 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Memorial Sloan Kettering Cancer Center:
|
Anxiety Black men Prostate Cancer 07-125 |
Additional relevant MeSH terms:
|
Prostatic Neoplasms Anxiety Disorders Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site |
Neoplasms Genital Diseases, Male Prostatic Diseases Mental Disorders |
ClinicalTrials.gov processed this record on September 27, 2016